We are delighted that several of our affiliated companies were recognised at the 2023 Cambridge Independent Science & Technology Awards last night. Among the list of awardees was Cardiatec Biosciences, an AI drug target discovery company co-founded by Milner Head of Computational Biology & AI Namshik Han, and Storm Therapeutics, a clinical stage biotechnology company co-founded by Milner Director Tony Kouzarides.
Milner affiliates won in the following categories:
Employer of the Year
The One to Watch
Winner: CardiaTec Biosciences
The Award for Innovation
Highly Commended: Enhanc3d Genomics
Biotech Company of the Year
Highly Commended: Storm Therapeutics
Congratulations to all of the winners and runners up in each category. The full list of awardees can be found at the Cambridge Independent website.